Cipher Pharmaceuticals Inc is on the rise, reflecting positive market sentiment.
Cipher Pharmaceuticals Inc (CPH.TO) is gaining today, with a notable increase of 1.82% to a closing price of CA$16.76. This upward movement highlights investor confidence in the company's potential amidst a competitive landscape.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Cipher Pharmaceuticals Inc
CPH.TO
CPH.TO
Cipher Pharmaceuticals Inc
WealthAwesomeMarket cap
$415.40M
P/E
9.7x
52W high
$20.56
52W low
$11.98
1W change
+0.12%
Beta
0.48
Analyst Price Targets
Based on analyst covering CPH
Wall Street analysts forecast CPH stock price to rise 25.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$20.64
+25.4% Upside
Current Price
C$16.46
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CPH's historical volatility
30-Day Vol
18.9%
Annualized
90-Day Vol
33.3%
Annualized
Trend (90d)
-40.1%
Annualized drift
90d Mean
C$14.26
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$15.69 | C$14.70 – C$16.75 |
| 60 trading days | C$14.96 | C$13.64 – C$16.40 |
| 90 trading days | C$14.26 | C$12.74 – C$15.96 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: The recent performance of Cipher Pharmaceuticals indicates a positive outlook, especially considering its strong financial results from previous quarters.
Cipher Pharmaceuticals Market Cap Surpasses CA$415 Million
With a market cap of CA$415.4 million, Cipher Pharmaceuticals is well-positioned for growth, but investors should keep an eye on market dynamics.
Bull case
Cipher's recent financial reports show impressive growth metrics, including a 135% increase in net income and significant rises in adjusted EBITDA. This suggests the company is effectively managing its operations and expanding its market presence.
Bear case
Despite the current gains, investors should stay cautious as the pharmaceutical sector can be volatile. Future regulatory challenges or increased market competition could affect Cipher's performance.
Advertisement
Recent Financial Performance
Cipher Pharmaceuticals has demonstrated strong financial health in its recent quarterly reports. For instance, the company reported a 135% increase in net income during Q1 2026, signaling solid operational efficiency and market demand for its products. Such performance metrics contribute to investor confidence and the stock's upward trajectory.
Market Sentiment and Future Outlook
The current gain in Cipher's stock price reflects a broader positive sentiment among investors. As the company continues to report strong earnings and revenue growth, it may attract more attention from institutional investors. However, potential challenges in the pharmaceutical industry, such as regulatory hurdles, could pose risks to its future performance. Investors are encouraged to monitor these developments closely.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
